APA (7th ed.) Citation

CH, T., YH, F., ATL, L., & WJ, H. (2022). Risk factors for pharmacotherapy for storage symptoms after transurethral resection of the prostate in patients with benign prostatic hyperplasia. Lower urinary tract symptoms, 14(5), 329. https://doi.org/10.1111/luts.12438

Chicago Style (17th ed.) Citation

CH, Tsai, Fan YH, Lin ATL, and Huang WJ. "Risk Factors for Pharmacotherapy for Storage Symptoms After Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia." Lower Urinary Tract Symptoms 14, no. 5 (2022): 329. https://doi.org/10.1111/luts.12438.

MLA (9th ed.) Citation

CH, Tsai, et al. "Risk Factors for Pharmacotherapy for Storage Symptoms After Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia." Lower Urinary Tract Symptoms, vol. 14, no. 5, 2022, p. 329, https://doi.org/10.1111/luts.12438.